previous compound ID: 438 next compound
InChIKey: DERZBLKQOCDDDZ-JLHYYAGUSA-N
SMILES: C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "R Robert" "SD Macknight" "J Goepp" "DY Thomas" "E Matthes" "B Kus" "GW Carlile" "D Rotin" "JW Hanrahan"

chemical graph of compound 438





CID is 1547484
synonyms found at PubChem are:
cinnarizine, Stugeron, 298-57-7, Dimitronal, Stutgin, Dimitron, Folcodal, Midronal, Mitronal, Stutgeron, Glanil, Labyrin, Lazeta, Marisan, Toliman, Sepan, Cinarizine, Cinnarizinum, Aplactan, Cinarizina, Cinnageron, Cinazyn, Cinaperazine, Libotasin, Senoger, Votegol, Zepamol, 1-Cinnamyl-4-(diphenylmethyl)piperazine, Cero-Aterin, R 516, 1-Benzhydryl-4-cinnamylpiperazin, Cinarizina [INN-Spanish], Cinnarizinum [INN-Latin], 516 MD, Processine, Sedatromin, Spaderizine, Aplexal, Apotomin, Carecin, Cerebolan, Cinnacet, Corathiem, Denapol, Giganten, Hilactan, Ixertol, Katoseran, Siptazin, Artate, Olamin, 1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine, Eglen, R 1575, Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-, Cinnarizine [USAN:INN:BAN:JAN], UNII-3DI2E1X18L, Cerepar, (E)-1-Benzhydryl-4-cinnamylpiperazine, 16699-20-0, 1-trans-Cinnamyl-4-diphenylmethylpiperazine, R-516, C26H28N2, EINECS 206-064-8, MD 516, 1-(diphenylmethyl)-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine, BRN 0626121, CHEMBL43064, Cinnarizine (JAN/USAN/INN), MLS000028498, 3DI2E1X18L, Piperazine, 1-cinnamyl-4-(diphenylmethyl)-, CHEBI:31403, 1-Benzhydryl-4-cinnamylpiperazine, DERZBLKQOCDDDZ-JLHYYAGUSA-N, N-Benzhydryl-N'-cinnamylpiperazine, 1-benzhydryl-4-[(E)-3-phenylprop-2-enyl]piperazine, Cinnipirine, 1-benzhydryl-4-[(E)-cinnamyl]piperazine, SMR000058307, DSSTox_CID_2821, C 5270, R-1575, DSSTox_RID_76744, DSSTox_GSID_22821, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazine, 4-((2E)-3-phenylprop-2-enyl)-1-(diphenylmethyl)piperazine, Stonoron, Cinnarizine Stugeron, SR-01000003093, 1-(Diphenylmethyl)-4-(3-phenyl-2-propen-1-yl)piperazine, Stunarone, 1-Cinnamyl-4-diphenylmethylpiperazine, Stunarone (TN), NCGC00015246-02, Stugeron (TN), CAS-298-57-7, Cinnarizine, powder, Prestwick_115, Piperazine, (E)-, AC1LU5GC, Opera_ID_1776, Prestwick2_000278, Prestwick3_000278, D0Q3YO, Lopac0_000314, SCHEMBL44957, SCHEMBL44958, BSPBio_000156, MLS001148649, MLS002207295, MLS002222167, ARONIS27007, BPBio1_000172, GTPL9072, DTXSID3022821, cid_1547484, AOB5321, CHEBI:131176, MolPort-002-056-760, HMS1568H18, HMS2095H18, HMS2234B20, HMS3260P10, HMS3712H18, component of Emesazine (Salt/Mix), 7002-58-6 (di-hydrochloride), EBD32904, HY-B1090, Tox21_110109, Tox21_500314, BDBM50017657, MFCD00056037, NSC290687, SBB057016, STK216257, ZINC19632891, AKOS002134299, Stugeron|Dimitronal|Stutgin|Cinarizine, Tox21_110109_1, CCG-204409, CS-4656, KS-5155, LP00314, NSC-290687, QTL1_000023, NCGC00018187-03, NCGC00018187-04, NCGC00018187-05, NCGC00018187-06, NCGC00018187-07, NCGC00018187-09, NCGC00021488-03, NCGC00021488-04, NCGC00021488-05, NCGC00260999-01, AN-25314, SC-14096, ST069378, LS-111394, EU-0100314, S4727, 1412-EP2275420A1, 1412-EP2280008A2, 1412-EP2298764A1, 1412-EP2298765A1, 1412-EP2305219A1, D01295, J10228, 298C577, A820077, L001227, 1-Benzhydryl-4-[3-phenyl-2-propenyl]piperazine #, I01-3582, SR-01000003093-2, SR-01000003093-6, W-106970, W-110442, 1-benzhydryl-4-[(2E)-3-phenylprop-2-enyl]piperazine, BRD-K07220430-001-03-6, BRD-K74927006-001-01-2, 1-[di(phenyl)methyl]-4-(3-phenylprop-2-enyl)piperazine, 1-(diphenylmethyl)-4-(3-phenylprop-2-en-1-yl)piperazine, 1-(diphenylmethyl)-4-[(E)-3-phenylprop-2-enyl]piperazine, Cinnarizine, European Pharmacopoeia (EP) Reference Standard, Cinnarizine; 1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazine